학술논문

Micronvasive behaviour of single small hepatocellular carcinoma: which treatment?
Original Article
Document Type
Clinical report
Source
Updates in Surgery. August 2021, Vol. 73 Issue 4, p1359, 11 p.
Subject
Drug therapy
Development and progression
Research
Prognosis
Comparative analysis
Cancer treatment -- Research -- Comparative analysis
Cancer -- Prognosis -- Development and progression -- Drug therapy
Ablation (Surgery) -- Research -- Comparative analysis
Cardiac patients -- Drug therapy -- Prognosis
Cancer metastasis -- Prognosis -- Development and progression -- Research -- Drug therapy
Metastasis -- Prognosis -- Development and progression -- Research -- Drug therapy
Cancer -- Care and treatment -- Prognosis -- Development and progression -- Drug therapy
Language
English
Abstract
Author(s): Roberto Santambrogio [sup.1], Matteo Barabino [sup.2], Valentina D'Alessandro [sup.1], Giulio Iacob [sup.1], Enrico Opocher [sup.2], Marco Gemma [sup.3], Marco Antonio Zappa [sup.1] Author Affiliations: (1) grid.507997.5, 0000 0004 5984 [...]
Background Microinvasion (MI), defined as infiltration of the portal or hepatic vein or bile duct and intrahepatic metastasis are accurate indicators of a poor prognosis for mall hepatocellular carcinomas (HCC). A previous study showed that intraoperative ultrasound (IOUS) definition of MI-HCC had a high concordance with histological findings. Aim of this study is to evaluate overall survival and recurrence patterns of patients with MI-HCC submitted to hepatic resection (HR) or laparoscopic ablation therapies (LAT). Methods A total of 171 consecutive patients (78 h; 93 LAT) with single, small HCC (< 3 cm) with a MI pattern at IOUS examination were compared analyzing overall survival and recurrence patterns using univariate and multivariate analysis and weighting by propensity score. Results Overall recurrences were similar in the 2 groups (HR: 51 patients (65%); LAT: 66 patients (71%)). The rate of local tumor progression in the HR group was very low (5 pts; 6%) in comparison to LAT group (22 pts; 24%; p = 0.002). The overall survival curves of HR are significantly better than that of the LAT group (p = 0.0039). On the propensity score Cox model, overall mortality was predicted by the surgical treatment with a Hazard ratio 1.68 (1.08-2.623) (p = 0.022). Conclusions If technically feasible and in patients fit for surgery, HR with an adequate tumor margin should be preferred to LAT in patients with MI-HCC at IOUS evaluation, to eradicate MI features near the main nodule, which are relatively frequent even in small HCC (< 3 cm).